Skye Bioscience, Inc. Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease)
Skye Bioscience, Inc. (SKYE) reported Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease) of $96.19 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes
us-gaap:CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease · last filed 2026-03-10
- Skye Bioscience, Inc. cumulative translation adjustment, net of tax, period increase (decrease) for fiscal 2025 was $96.19K.
- Skye Bioscience, Inc. cumulative translation adjustment, net of tax, period increase (decrease) for fiscal 2024 was -$148.02K, a 339.65% decline from fiscal 2023.
- Skye Bioscience, Inc. cumulative translation adjustment, net of tax, period increase (decrease) for fiscal 2023 was $61.77K, a 3.06% decline from fiscal 2022.
- Skye Bioscience, Inc. cumulative translation adjustment, net of tax, period increase (decrease) for fiscal 2022 was $63.72K, a 853.28% increase from fiscal 2021.
| Period end | Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease) 12 month | Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease) 12 month as first filed |
|---|---|---|
| 2025-12-31 | $96.19K 10-K · filed 2026-03-10 | |
| 2024-12-31 | -$148.02K 10-K · filed 2026-03-10 | $148.02K 10-K · filed 2025-03-20 |
| 2023-12-31 | $61.77K 10-K · filed 2025-03-20 | |
| 2022-12-31 | $63.72K 10-K · filed 2024-03-22 | |
| 2021-12-31 | $6.68K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |